A Study of Sulfatinib on Relapsed or Refractory Drug Resistant Osteosarcoma

NCT05590572 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
NOT_YET_RECRUITING
Status
148
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University

Collaborators